These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

42 related articles for article (PubMed ID: 2585084)

  • 1. Effects of ML-9 on experimental delayed cerebral vasospasm.
    Kokubu K; Tani E; Nakano M; Minami N; Shindo H
    J Neurosurg; 1989 Dec; 71(6):916-22. PubMed ID: 2585084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of chlorpromazine on experimental delayed cerebral vasospasm.
    Nakano M; Tani E; Fukumori T; Yokota M
    J Neurosurg; 1984 Nov; 61(5):857-63. PubMed ID: 6491731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of inhibitors of protein kinase C and calpain in experimental delayed cerebral vasospasm.
    Minami N; Tani E; Maeda Y; Yamaura I; Fukami M
    J Neurosurg; 1992 Jan; 76(1):111-8. PubMed ID: 1370069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Relief of experimental cerebral vasospasm by the intrathecal administration of a calcium antagonist (diltiazem)--in comparison with intra-arterial administration].
    Fukuoka H; Takagi T; Nagai H; Hotta K; Fujimoto S; Naitoh K
    No Shinkei Geka; 1985 Aug; 13(8):839-43. PubMed ID: 3840580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of 5-lipoxygenase inhibitor on experimental delayed cerebral vasospasm.
    Yokota M; Tani E; Maeda Y; Kokubu K
    Stroke; 1987; 18(2):512-8. PubMed ID: 3564111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimal cerebrospinal fluid magnesium ion concentration for vasodilatory effect and duration after intracisternal injection of magnesium sulfate solution in a canine subarachnoid hemorrhage model.
    Mori K; Yamamoto T; Miyazaki M; Hara Y; Aiko Y; Koike N; Sakamoto S; Nakao Y; Esaki T
    J Neurosurg; 2011 Apr; 114(4):1168-75. PubMed ID: 21073257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of vasodilation by milrinone, a phosphodiesterase III inhibitor, on vasospastic arteries after a subarachnoid hemorrhage in vitro and in vivo: effectiveness of cisternal injection of milrinone.
    Nishiguchi M; Ono S; Iseda K; Manabe H; Hishikawa T; Date I
    Neurosurgery; 2010 Jan; 66(1):158-64; discussion 164. PubMed ID: 20023546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The effect of nimodipine and papaverine on delayed cerebral vasospasm in dogs].
    Liu F; Liu D; Rao M
    Zhonghua Yi Xue Za Zhi; 1996 Feb; 76(2):132-4. PubMed ID: 8758447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of prostacyclin and indomethacin on experimental delayed cerebral vasospasm.
    Fukumori T; Tani E; Maeda Y; Sukenaga A
    J Neurosurg; 1983 Nov; 59(5):829-34. PubMed ID: 6352874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of selective inhibitor of thromboxane A2 synthetase on experimental cerebral vasospasm.
    Fukumori T; Tani E; Maeda Y; Sukenaga A
    Stroke; 1984; 15(2):306-11. PubMed ID: 6538355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel vasodilatory effect of intracisternal injection of magnesium sulfate solution on spastic cerebral arteries in the canine two-hemorrhage model of subarachnoid hemorrhage.
    Mori K; Miyazaki M; Hara Y; Aiko Y; Yamamoto T; Nakao Y
    J Neurosurg; 2009 Jan; 110(1):73-8. PubMed ID: 18834261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of protein kinases in canine basilar artery in vasospasm.
    Fujikawa H; Tani E; Yamaura I; Ozaki I; Miyaji K; Sato M; Takahashi K; Imajoh-Ohmi S
    J Cereb Blood Flow Metab; 1999 Jan; 19(1):44-52. PubMed ID: 9886354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of intrathecal magnesium sulfate solution injection via a microcatheter in the cisterna magna on cerebral vasospasm in the canine subarachnoid haemorrhage model.
    Mori K; Yamamoto T; Miyazaki M; Hara Y; Aiko Y; Koike N; Sakamoto S; Nakao Y; Esaki T
    Br J Neurosurg; 2012 Feb; 26(1):64-8. PubMed ID: 21767131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification, characterization, and functional role of phosphodiesterase type IV in cerebral vessels: effects of selective phosphodiesterase inhibitors.
    Willette RN; Shiloh AO; Sauermelch CF; Sulpizio A; Michell MP; Cieslinski LB; Torphy TJ; Ohlstein EH
    J Cereb Blood Flow Metab; 1997 Feb; 17(2):210-9. PubMed ID: 9040501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cerebral vasospasm and vasoactive amines (author's transl)].
    Kuwayama A
    No Shinkei Geka; 1975 Dec; 3(12):1001-7. PubMed ID: 1241109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reversal of experimental cerebral vasospasm by intravenous nitroprusside therapy.
    Heros RC; Zervas NT; Lavyne MH; Pickren KS
    Surg Neurol; 1976 Oct; 6(4):227-9. PubMed ID: 968722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of diltiazem on experimental cerebral vasospasm incomparison with effects of cinnarizine, verapamil and nifedipine].
    Takagi T; Fukuoka H; Kamiya K; Nagai H; Hotta K
    No Shinkei Geka; 1983 Jun; 11(6):605-11. PubMed ID: 6621784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo characterization of vasocontractile activities in erythrocytes.
    McIlhany MP; Johns LM; Leipzig T; Patronas NJ; Brown FD; Mullan SF
    J Neurosurg; 1983 Mar; 58(3):356-61. PubMed ID: 6827319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Possible role of protein kinase C-dependent smooth muscle contraction in the pathogenesis of chronic cerebral vasospasm.
    Matsui T; Takuwa Y; Johshita H; Yamashita K; Asano T
    J Cereb Blood Flow Metab; 1991 Jan; 11(1):143-9. PubMed ID: 1983998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebral aterial spasm. I. Adrenergic mechanism in experimental cerebral vasospasm.
    Morooka H
    Acta Med Okayama; 1978 Apr; 32(1):23-37. PubMed ID: 148833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.